ArticleEuropean journal of radiology open2024
Study on the classification of benign and malignant breast lesions using a multi-sequence breast MRI fusion radiomics and deep learning model.
Article in European journal of radiology open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiparametric MRI deep learning model based on dynamic Contrast-enhanced and apparent diffusion coefficient map enables accurate prediction of benign and malignant breast lesions.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop a multi-modal model combining multi-sequence breast MRI fusion radiomics and deep learning for the classification of benign and malignant breast lesions, to assist clinicians in better selecting treatment plans. Methods: A total of 314 patients who underwent breast MRI examinations were included. They were randomly divided into training, validation, and test sets in a ratio of 7:1:2. Subsequently, features of T1-weighted images (T1WI), T2-weighted images (T2WI), and dynamic contrast-enhanced MRI (DCE-MRI) were extracted using the convolutional neural network ResNet50 for fusion, and then combined with radiomic features from the three sequences. The following models were established: T1 model, T2 model, DCE model, DCE_T1_T2 model, and DCE_T1_T2_rad model. The performance of the models was evaluated by the area under the receiver operating characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. The differences between the DCE_T1_T2_rad model and the other four models were compared using the Delong test, with a Results: The five models established in this study performed well, with AUC values of 0.53 for the T1 model, 0.62 for the T2 model, 0.79 for the DCE model, 0.94 for the DCE_T1_T2 model, and 0.98 for the DCE_T1_T2_rad model. The DCE_T1_T2_rad model showed statistically significant differences ( Conclusion: The use of a multi-modal model combining multi-sequence breast MRI fusion radiomics and deep learning can effectively improve the diagnostic performance of breast lesion classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.